日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The depletion of serine beta-lactamase-like protein (LACTB) ameliorates metabolic dysfunction-associated steatotic liver disease by reducing ubiquitin-mediated degradation of carnitine palmitoyltransferase 2.

丝氨酸β-内酰胺酶样蛋白(LACTB)的耗竭通过减少肉碱棕榈酰转移酶2的泛素介导降解来改善代谢功能障碍相关的脂肪肝疾病。

Shi Wujiang, Liu Xin, Wang Nan, Zhang Qianwen, Gao Jianjun, Guan Canghai, Li Yapeng, Yang Chengru, Bi Shaowu, Zou Xinlei, Zhong Xiangyu

A Novel 167-Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination

一种由 CircPCSK6 编码的新型 167 个氨基酸的蛋白质通过 IKBα 泛素化抑制肝内胆管癌的进展。

Guan, Canghai; Gao, Jianjun; Zou, Xinlei; Shi, Wujiang; Hao, Yunhe; Ge, Yifei; Xu, Zhaoqiang; Yang, Chengru; Bi, Shaowu; Jiang, Xingming; Kang, Pengcheng; Xu, Xiaoxue; Zhong, Xiangyu

Feedback loop LINC00511-YTHDF2-SOX2 regulatory network drives cholangiocarcinoma progression and stemness

LINC00511-YTHDF2-SOX2 反馈回路调控网络驱动胆管癌进展和干性

Guan, Canghai; Zou, Xinlei; Gao, Xin; Liu, Sidi; Gao, Jianjun; Shi, Wujiang; Dong, Qingfu; Jiang, Xingming; Zhong, Xiangyu

Polyribonucleotide nucleotidyltransferase 1 participates in metabolic-associated fatty liver disease pathogenesis by affecting lipid metabolism and mitochondrial homeostasis.

多核糖核苷酸核苷酸转移酶 1 通过影响脂质代谢和线粒体稳态参与代谢相关脂肪肝疾病的发病机制

Guan Canghai, Zou Xinlei, Yang Chengru, Shi Wujiang, Gao Jianjun, Ge Yifei, Xu Zhaoqiang, Bi Shaowu, Zhong Xiangyu

Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research

Forkhead box O1 在代谢功能障碍相关脂肪肝疾病中的作用:分子机制和药物研究

Sha, Xiangjun; Zou, Xinlei; Liu, Sidi; Guan, Canghai; Shi, Wujiang; Gao, Jianjun; Zhong, Xiangyu; Jiang, Xingming

Utilization of 3D printing technology in hepatopancreatobiliary surgery

3D打印技术在肝胆胰外科手术中的应用

Shi, Wujiang; Wang, Jiangang; Gao, Jianjun; Zou, Xinlei; Dong, Qingfu; Huang, Ziyue; Sheng, Jialin; Guan, Canghai; Xu, Yi; Cui, Yunfu; Zhong, Xiangyu

Research progress and applications of epigenetic biomarkers in cancer

表观遗传生物标志物在癌症中的研究进展及应用

Gao, Jianjun; Shi, Wujiang; Wang, Jiangang; Guan, Canghai; Dong, Qingfu; Sheng, Jialin; Zou, Xinlei; Xu, Zhaoqiang; Ge, Yifei; Yang, Chengru; Li, Jiehan; Bao, Haolin; Zhong, Xiangyu; Cui, Yunfu

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

转移性胰腺导管腺癌药物治疗进展

Gao, Jianjun; Wang, Jiangang; Guan, Canghai; Shi, Wujiang; Dong, Qingfu; Sheng, Jialin; Zou, Xinlei; Xu, Zhaoqiang; Ge, Yifei; Huang, Ziyue; Li, Jiehan; Bao, Haolin; Xu, Yi; Cui, Yunfu; Xu, Xiaoxue; Zhong, Xiangyu

Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy

胰腺癌中的三级淋巴结构:免疫治疗的新靶点

Zou, Xinlei; Guan, Canghai; Gao, Jianjun; Shi, Wujiang; Cui, Yunfu; Zhong, Xiangyu

Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies

肝纤维化和代谢相关脂肪性肝病:多药联合治疗策略的探索

Dong, Qingfu; Bao, Haolin; Wang, Jiangang; Shi, Wujiang; Zou, Xinlei; Sheng, Jialin; Gao, Jianjun; Guan, Canghai; Xia, Haoming; Li, Jinglin; Kang, Pengcheng; Xu, Yi; Cui, Yunfu; Zhong, Xiangyu